Hypertension Flashcards
1
Q
History in confirmed hypertension
A
- Duration and Previous treatment
- Past/current symptoms
IHD
Heart failure
Cerebrovascular disease
Peripheral arterial disease - Symptoms of CKD
Oliguria
Nocturia
Hematuria - Suggestions of secondary cause
Cushings: weight, mood, acne, myopathy, menstrual
Conns: fatigue, headA, parasthesia
Phaeochromocytoma: sweating, headA, tachyC
Sleep apnea: daytime sleep, snoring, obesity
Nephrogenic: PCKD, RAS, GN
HyperPTH: stones, bone, groans, psychic moans - Other chronic conditions influencing management/+CV risk
Asthma, COPD
Diabetes
Lipids
DM
CKD
Alcoholism
Heart failure - Lifestyle
Smoking
Alcohol
Diet
Physical activity
Weight - Medication, FHx, occupation etc
2
Q
Physical examination
A
- Vitals
- Evidence of underlying cause
Endocrine
Focal neurological - Complications
CVS: ++pulse, CCF, bruits, PVD, aneurysms
Palpable kidneys, bruits
Optic fundi: nipping, hemorrhage, exudates, cotton wool, papilloedema
3
Q
Goals of HTN evaluation
A
- Identify all risk factors
- Detect end organ damage
- Identify secondary causes
4
Q
Overview of management
A
1. Lifestyle Weight reduction Diet Limit alcohol Physical activity Smoking cessation 2. Pharmacotherapy 3. Manage comorbidities Low dose aspirin Lipid management Diabetes management
5
Q
Principles of drug treatment
A
- Start with lowest does
- If not tolerated->change
- If not managed 6 weeks->add second drug
- Still not, tolerated->+dose of one type
- Can add third drug
- Consider other reasons for non-responding
6
Q
When is pharmacotherapy intervention required immediately
A
When >180/110, >160/15% CVD risk
ATSI w/ hypertension
7
Q
Associated conditions
A
PVD \+Cholesterol >7.5 CKD Diabetes Aortic FHx of premature CVD Cerebrovascular CAD
8
Q
Evidence of end organ
A
- CKD: proteinuria:creatinin >30mg/mmol, >300mg protein, eGFR a:cr >2 M, >2.5 F
- LVH on ECG
- Vascular disease->bruits, HTN retinopathy
9
Q
Options for pharmacotherapy
A
- ACEi
- ARB
- B blocker
- CCB
- Diuretics
10
Q
Defining
A
High normal 130-139/85-89
Mild 140-159/90-99
Moderate 160-179/100-109
Severe >180/110
11
Q
Grading HTN retinopathy
A
- Tortuous silver/copper wiring
- AV nipping
- Flame hemorrhages and cotton wool spots
- Papilloedema
12
Q
Define malignant hypertension
A
Systolic >200/130 + bilateral retinal hemorrhages and exudates +papilloedema (may or may not)
13
Q
Management of malignant and why
A
Renal failure, cardiac failure, encephalopathy
Fibriniod necrosis
14
Q
Investigations in HTN
A
1. Quantify risk Glucose Cholesterol 2. End organ damage ECG Urinalysis UEC FBC and Hct 3. Exclude secondary UEC (low K in conns), +Ca in hyperPTH Consider other secondary tests TSH
15
Q
Treatment resistance
A
- Volume overload->CKD
- White coat
- Medications that +BP
- Secondary causes
- Non-adherence
- Undisclosed alcohol/drug use
- Sleep apnea
- High salt